| Product Code: ETC4538005 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The India human milk oligosaccharides (HMO) market is emerging as consumers and manufacturers recognize the importance of these compounds in infant nutrition. HMOs are complex sugars found in human breast milk, and they play a crucial role in supporting infant health, particularly in the development of a healthy gut microbiome. As breastfeeding gains prominence and as research highlights the benefits of HMOs, the market for HMO-based infant formulas and supplements is growing. India HMO market is expected to continue expanding as more parents seek nutritionally advanced options for their babies.
The India HMO market is experiencing growth due to the growing interest in infant nutrition and maternal health. HMOs are considered crucial for infant development and immune system support. As more India parents recognize the significance of breast milk and its components, the demand for HMO-enriched infant formula and maternal supplements is increasing. Research and development in the field of HMOs are further driving this market`s expansion.
The India human milk oligosaccharides (HMO) market faces several challenges, primarily related to the unique nature of the product and its potential benefits. One of the main obstacles is the high cost of production and purification of HMOs, making it difficult to offer affordable HMO-based products to a broader consumer base. Quality control and safety standards are paramount, given the potential health implications of HMOs, which necessitate rigorous testing and compliance with regulatory requirements. The market also faces the challenge of educating both consumers and healthcare professionals about the benefits of HMOs, as this is a relatively new and specialized area. Moreover, the market needs to keep pace with evolving scientific research and adapt to changing consumer preferences for infant nutrition. In a competitive landscape, companies must invest in research and development to innovate and develop new HMO-based products and applications.
The emphasis on infant health and nutrition remained strong during the pandemic. The HMO market catered to this demand by offering products that mimic the nutritional benefits of human milk.
Key players in the India HMO market include Glycom A/S, Inbiose NV, Jennewein Biotechnologie GmbH, and DuPont Nutrition & Biosciences.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Human Milk Oligosaccharides (HMO) Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 & 2031F |
3.3 India Human Milk Oligosaccharides (HMO) Market - Industry Life Cycle |
3.4 India Human Milk Oligosaccharides (HMO) Market - Porter's Five Forces |
3.5 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Concentration, 2021 & 2031F |
4 India Human Milk Oligosaccharides (HMO) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing awareness about the health benefits of human milk oligosaccharides (HMOs) for infants |
4.2.2 Increasing demand for baby formulas fortified with HMOs |
4.2.3 Rising prevalence of infant health issues, leading to a focus on nutrition and immunity |
4.3 Market Restraints |
4.3.1 High production costs associated with extracting and synthesizing HMOs |
4.3.2 Limited availability and access to HMO-enriched products |
4.3.3 Regulatory challenges and strict guidelines for infant nutrition products |
5 India Human Milk Oligosaccharides (HMO) Market Trends |
6 India Human Milk Oligosaccharides (HMO) Market, By Types |
6.1 India Human Milk Oligosaccharides (HMO) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 2?? Fl, 2021-2031F |
6.1.4 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Fl, 2021-2031F |
6.1.5 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Sl, 2021-2031F |
6.1.6 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 6?? Sl, 2021-2031F |
6.2 India Human Milk Oligosaccharides (HMO) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Infant Formula, 2021-2031F |
6.2.3 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Functional Food & Beverages, 2021-2031F |
6.2.4 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Food Supplement, 2021-2031F |
6.3 India Human Milk Oligosaccharides (HMO) Market, By Concentration |
6.3.1 Overview and Analysis |
6.3.2 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Neutral, 2021-2031F |
6.3.3 India Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Acidic, 2021-2031F |
7 India Human Milk Oligosaccharides (HMO) Market Import-Export Trade Statistics |
7.1 India Human Milk Oligosaccharides (HMO) Market Export to Major Countries |
7.2 India Human Milk Oligosaccharides (HMO) Market Imports from Major Countries |
8 India Human Milk Oligosaccharides (HMO) Market Key Performance Indicators |
8.1 Research and development investment in HMO-enriched products |
8.2 Adoption rate of HMO-fortified baby formulas by major infant formula brands |
8.3 Number of clinical studies demonstrating the effectiveness of HMOs in infant nutrition |
9 India Human Milk Oligosaccharides (HMO) Market - Opportunity Assessment |
9.1 India Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Concentration, 2021 & 2031F |
10 India Human Milk Oligosaccharides (HMO) Market - Competitive Landscape |
10.1 India Human Milk Oligosaccharides (HMO) Market Revenue Share, By Companies, 2024 |
10.2 India Human Milk Oligosaccharides (HMO) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here